PATENT CLAIM ANALYSIS

Application Number: 15906268
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "233200"]

Abstract:
The present invention is directed to novel compounds of formula I and their use as therapeutic compounds.

Claim (Index 18):
The pharmaceutical composition according to  claim 17  comprising a compound of formula Ib or a pharmaceutically acceptable salt or solvate thereof and at least one pharmaceutically acceptable carrier, diluent, excipient and/or adjuvant, wherein Ar 1 , Ar 2 , R 1 , R 1\u2032 , R 2 , R 2\u2032 , R 3 , R 3\u2032 , X 1 , X 2 , are as defined in claim  1 .

Metadata:
- Claim Count in Document: 32.0
- Percentile: 88.0
- Lexical Diversity: 1.05882
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14349595', '14799208', '13627091', '15259922', '15205304']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8124937514040101
- 35 USC 102 Novelty (BERT): 0.6309077412191874
- Combined Prediction Score: 0.7943351503855279
- Mean Citation Score: 548.391766
- Max Citation Score: 607.86743
- Similarity Product: 532.8055188733423

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test